6:18 PM
 | 
Jun 12, 2006
 |  BC Extra  |  Company News

Saforis gets Priority Review

FDA accepted for filing and granted Priority Review to an NDA from MGI Pharma (MOGN) for...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >